A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters
Clinical trial NCT05137236 · COMPLETED
Trial details
- NCT number
- NCT05137236
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-06
- Primary completion
- 2023-03-23
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.